|
2025-04-11 |
2025-04-10 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
1,000
-8.7%
41.89
USD 1,040,967
|
1,000
-8.7%
|
41.89
|
USD 100,000
|
|
|
2025-04-11 |
2025-04-09 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
1,000
-8.7%
41.11
USD 1,021,584
|
1,000
-8.7%
|
41.11
|
USD 100,000
|
|
|
2025-03-14 |
2025-03-13 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
26,592
-9.3%
45.78
USD 1,217,382
|
26,592
-9.3%
|
45.78
|
USD 1,217,382
|
|
|
2025-03-14 |
2025-03-12 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
26,591
-9.3%
46.31
USD 1,231,429
|
26,591
-9.3%
|
46.31
|
USD 1,231,429
|
|
|
2025-03-05 |
2025-03-03 |
PS
Planned sale
|
Halpin Michael
Chief Operating Officer
Officer
|
10,000
-39.2%
49.52
USD 495,200
|
10,000
-39.2%
|
49.52
|
USD 495,200
|
|
|
2025-03-05 |
2025-03-03 |
PS
Planned sale
|
Mara Joseph Anthony Jr
Chief Financial Officer
Officer
|
9,000
-39.2%
49.53
USD 445,770
|
9,000
-39.2%
|
49.53
|
USD 445,770
|
|
|
2025-03-05 |
2025-03-03 |
PS
Planned sale
|
Hagen Heidi
Non-Executive Director
|
9,000
-23.9%
49.53
USD 445,770
|
9,000
-23.9%
|
49.53
|
USD 445,770
|
|
|
2025-03-05 |
2025-03-03 |
PS
Planned sale
|
Hopper Jonathan Mark
Chief Medical Officer
Officer
|
10,000
-13.1%
49.53
USD 495,300
|
10,000
-13.1%
|
49.53
|
USD 495,300
|
|
|
2025-02-26 |
2025-02-25 |
PS
Planned sale
|
SIEGAL JONATHAN
Principal Accounting Officer
Officer
|
1,137
-48.5%
52.07
USD 59,204
|
1,137
-48.5%
|
52.07
|
USD 59,204
|
|
|
2025-02-26 |
2025-02-25 |
PS
Planned sale
|
Flynn Sean C.
Chief Legal Officer
Officer
|
1,669
-68.8%
52.07
USD 86,905
|
1,669
-68.8%
|
52.07
|
USD 86,905
|
|
|
2025-02-24 |
2025-02-20 |
PS
Planned sale
|
Flynn Sean C.
Chief Legal Officer
Officer
|
3,835
-83.5%
57.32
USD 219,822
|
3,835
-83.5%
|
57.32
|
USD 219,822
|
|
|
2025-02-20 |
2025-02-19 |
PS
Planned sale
|
SIEGAL JONATHAN
Principal Accounting Officer
Officer
|
1,710
-58.6%
56.72
USD 96,991
|
1,710
-58.6%
|
56.72
|
USD 96,991
|
|
|
2025-02-14 |
2025-02-12 |
PS
Planned sale
|
MCLAUGHLIN KEVIN F
Non-Executive Director
|
1,000
-7.8%
55.43
USD 55,430
|
1,000
-7.8%
|
55.43
|
USD 55,430
|
|
|
2025-02-14 |
2025-02-12 |
PS
Planned sale
|
MCLAUGHLIN KEVIN F
Non-Executive Director
|
6,000
-33.5%
55.47
USD 332,820
|
6,000
-33.5%
|
55.47
|
USD 332,820
|
|
|
2025-02-07 |
2025-02-05 |
PS
Planned sale
|
SIEGAL JONATHAN
Principal Accounting Officer
Officer
|
1,092
-47.5%
61.99
USD 67,693
|
1,092
-47.5%
|
61.99
|
USD 67,693
|
|
|
2025-02-07 |
2025-02-05 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
2,500
-8.6%
62.50
USD 156,250
|
2,500
-8.6%
|
62.50
|
USD 156,250
|
|
|
2025-01-30 |
2025-01-28 |
PS
Planned sale
|
SIEGAL JONATHAN
Principal Accounting Officer
Officer
|
3,908
-76.4%
61.99
USD 242,257
|
3,908
-76.4%
|
61.99
|
USD 242,257
|
|
|
2024-12-05 |
2024-12-04 |
S
Sale
|
Wotton Paul K
Non-Executive Director
|
2,600
-8.7%
58.72
USD 152,672
|
2,600
-8.7%
|
58.72
|
USD 152,672
|
|
|
2024-12-03 |
2024-12-02 |
PS
Planned sale
|
Hopper Jonathan Mark
Chief Medical Officer
Officer
|
10,000
-14.6%
58.72
USD 587,200
|
10,000
-14.6%
|
58.72
|
USD 587,200
|
|
|
2024-11-25 |
2024-11-22 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
2,500
-8.6%
60.00
USD 150,000
|
2,500
-8.6%
|
60.00
|
USD 150,000
|
|
|
2024-11-15 |
2024-11-14 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
53.93
USD 943,775
|
17,500
-7.3%
|
53.93
|
USD 943,775
|
|
|
2024-11-15 |
2024-11-13 |
PS
Planned sale
|
MCLAUGHLIN KEVIN F
Non-Executive Director
|
7,000
-37.0%
55.54
USD 388,780
|
7,000
-37.0%
|
55.54
|
USD 388,780
|
|
|
2024-11-15 |
2024-11-13 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
55.57
USD 972,475
|
17,500
-7.3%
|
55.57
|
USD 972,475
|
|
|
2024-11-13 |
2024-11-12 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
2,500
-8.6%
57.50
USD 143,750
|
2,500
-8.6%
|
57.50
|
USD 143,750
|
|
|
2024-11-13 |
2024-11-11 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
2,500
-8.6%
55.00
USD 137,500
|
2,500
-8.6%
|
55.00
|
USD 137,500
|
|
|
2024-10-18 |
2024-10-17 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
40.34
USD 705,950
|
17,500
-7.3%
|
40.34
|
USD 705,950
|
|
|
2024-10-18 |
2024-10-16 |
PS
Planned sale
|
GILMAN STEVEN C
Non-Executive Director
|
5,833
-34.7%
41.36
USD 241,253
|
5,833
-34.7%
|
41.36
|
USD 241,253
|
|
|
2024-10-18 |
2024-10-16 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
41.38
USD 724,150
|
17,500
-7.3%
|
41.38
|
USD 724,150
|
|
|
2024-10-04 |
2024-10-02 |
PS
Planned sale
|
GILMAN STEVEN C
Non-Executive Director
|
5,833
-34.7%
40.35
USD 235,362
|
5,833
-34.7%
|
40.35
|
USD 235,362
|
|
|
2024-10-02 |
2024-10-01 |
PS
Planned sale
|
SIEGAL JONATHAN
Principal Accounting Officer
Officer
|
568
-33.6%
41.90
USD 23,799
|
568
-33.6%
|
41.90
|
USD 23,799
|
|
|
2024-09-20 |
2024-09-18 |
PS
Planned sale
|
GILMAN STEVEN C
Non-Executive Director
|
5,834
-34.7%
45.54
USD 265,680
|
5,834
-34.7%
|
45.54
|
USD 265,680
|
|
|
2024-09-13 |
2024-09-12 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
43.90
USD 768,250
|
17,500
-7.3%
|
43.90
|
USD 768,250
|
|
|
2024-09-13 |
2024-09-11 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
43.37
USD 758,975
|
17,500
-7.3%
|
43.37
|
USD 758,975
|
|
|
2024-09-05 |
2024-09-04 |
PS
Planned sale
|
GILMAN STEVEN C
Non-Executive Director
|
5,000
-31.2%
48.58
USD 242,900
|
5,000
-31.2%
|
48.58
|
USD 242,900
|
|
|
2024-09-05 |
2024-09-03 |
PS
Planned sale
|
Hopper Jonathan Mark
Chief Medical Officer
Officer
|
10,000
-14.7%
49.83
USD 498,300
|
10,000
-14.7%
|
49.83
|
USD 498,300
|
|
|
2024-08-16 |
2024-08-15 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
46.24
USD 809,200
|
17,500
-7.3%
|
46.24
|
USD 809,200
|
|
|
2024-08-16 |
2024-08-14 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
45.17
USD 790,475
|
17,500
-7.3%
|
45.17
|
USD 790,475
|
|
|
2024-08-09 |
2024-08-07 |
PS
Planned sale
|
MCLAUGHLIN KEVIN F
Non-Executive Director
|
2,000
-14.4%
45.99
USD 91,980
|
2,000
-14.4%
|
45.99
|
USD 91,980
|
|
|
2024-08-09 |
2024-08-07 |
PS
Planned sale
|
MCLAUGHLIN KEVIN F
Non-Executive Director
|
5,000
-29.6%
45.92
USD 229,600
|
5,000
-29.6%
|
45.92
|
USD 229,600
|
|
|
2024-07-19 |
2024-07-18 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
51.40
USD 899,500
|
17,500
-7.3%
|
51.40
|
USD 899,500
|
|
|
2024-07-19 |
2024-07-17 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
51.55
USD 902,125
|
17,500
-7.3%
|
51.55
|
USD 902,125
|
|
|
2024-07-18 |
2024-07-16 |
PS
Planned sale
|
Flynn Sean C.
Chief Legal Officer
Officer
|
15,000
-95.5%
52.18
USD 782,700
|
15,000
-95.5%
|
52.18
|
USD 782,700
|
|
|
2024-07-16 |
2024-07-12 |
PS
Planned sale
|
Mara Joseph Anthony Jr
Chief Financial Officer
Officer
|
5,000
-25.7%
50.00
USD 250,000
|
5,000
-25.7%
|
50.00
|
USD 250,000
|
|
|
2024-07-09 |
2024-07-05 |
PS
Planned sale
|
SIEGAL JONATHAN
Principal Accounting Officer
Officer
|
545
-34.5%
45.00
USD 24,525
|
545
-34.5%
|
45.00
|
USD 24,525
|
|
|
2024-06-24 |
2024-06-24 |
PS
Planned sale
|
Flynn Sean C.
Chief Legal Officer
Officer
|
1,474
-75.2%
45.84
USD 67,568
|
1,474
-75.2%
|
45.84
|
USD 67,568
|
|
|
2024-06-24 |
2024-06-21 |
PS
Planned sale
|
Flynn Sean C.
Chief Legal Officer
Officer
|
6,772
-93.3%
45.02
USD 304,875
|
6,772
-93.3%
|
45.02
|
USD 304,875
|
|
|
2024-06-24 |
2024-06-20 |
PS
Planned sale
|
Flynn Sean C.
Chief Legal Officer
Officer
|
6,754
-93.3%
45.04
USD 304,200
|
6,754
-93.3%
|
45.04
|
USD 304,200
|
|
|
2024-06-14 |
2024-06-13 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
43.10
USD 754,250
|
17,500
-7.3%
|
43.10
|
USD 754,250
|
|
|
2024-06-14 |
2024-06-12 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
44.12
USD 772,100
|
17,500
-7.3%
|
44.12
|
USD 772,100
|
|
|
2024-05-21 |
2024-05-20 |
PS
Planned sale
|
Hopper Jonathan Mark
Chief Medical Officer
Officer
|
10,000
-14.7%
49.99
USD 499,900
|
10,000
-14.7%
|
49.99
|
USD 499,900
|
|
|
2024-05-17 |
2024-05-16 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
47.85
USD 837,375
|
17,500
-7.3%
|
47.85
|
USD 837,375
|
|
|
2024-05-17 |
2024-05-15 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-7.3%
49.67
USD 869,225
|
17,500
-7.3%
|
49.67
|
USD 869,225
|
|
|
2024-04-19 |
2024-04-18 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-8.2%
44.59
USD 780,325
|
17,500
-8.2%
|
44.59
|
USD 780,325
|
|
|
2024-04-19 |
2024-04-17 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-8.2%
46.47
USD 813,225
|
17,500
-8.2%
|
46.47
|
USD 813,225
|
|
|
2024-03-29 |
2024-03-27 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
3,278
-12.3%
51.57
USD 169,046
|
3,278
-12.3%
|
51.57
|
USD 169,046
|
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-8.2%
44.02
USD 770,350
|
17,500
-8.2%
|
44.02
|
USD 770,350
|
|
|
2024-03-15 |
2024-03-13 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-8.2%
44.67
USD 781,725
|
17,500
-8.2%
|
44.67
|
USD 781,725
|
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Halpin Michael
Chief Operating Officer
Officer
|
7,874
-89.2%
44.71
USD 352,047
|
7,874
-89.2%
|
44.71
|
USD 352,047
|
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
Flynn Sean C.
SVP, General Counsel
Officer
|
8,115
-98.0%
45.33
USD 367,853
|
8,115
-98.0%
|
45.33
|
USD 367,853
|
|
|
2024-03-11 |
2024-03-07 |
PS
Planned sale
|
SIEGAL JONATHAN
Principal Accounting Officer
Officer
|
1,634
-53.9%
45.00
USD 73,530
|
1,634
-53.9%
|
45.00
|
USD 73,530
|
|
|
2024-02-22 |
2024-02-20 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
722
-3.0%
50.01
USD 36,107
|
722
-3.0%
|
50.01
|
USD 36,107
|
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-9.1%
48.85
USD 854,875
|
17,500
-9.1%
|
48.85
|
USD 854,875
|
|
|
2024-02-16 |
2024-02-14 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
17,500
-9.1%
46.99
USD 822,325
|
17,500
-9.1%
|
46.99
|
USD 822,325
|
|
|
2024-01-30 |
2024-01-29 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
2,300
-9.0%
44.22
USD 101,706
|
2,300
-9.0%
|
44.22
|
USD 101,706
|
|
|
2024-01-29 |
2024-01-25 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
200
-0.8%
44.02
USD 8,804
|
200
-0.8%
|
44.02
|
USD 8,804
|
|
|
2024-01-24 |
2024-01-22 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
3,000
-10.4%
42.05
USD 126,150
|
3,000
-10.4%
|
42.05
|
USD 126,150
|
|
|
2024-01-24 |
2024-01-22 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
2,500
-8.8%
42.06
USD 105,150
|
2,500
-8.8%
|
42.06
|
USD 105,150
|
|
|
2024-01-24 |
2024-01-22 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
2,500
-8.1%
41.39
USD 103,475
|
2,500
-8.1%
|
41.39
|
USD 103,475
|
|
|
2024-01-19 |
2024-01-18 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
16,726
-9.0%
38.58
USD 645,289
|
16,726
-9.0%
|
38.58
|
USD 645,289
|
|
|
2024-01-19 |
2024-01-17 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
16,726
-9.0%
37.97
USD 635,086
|
16,726
-9.0%
|
37.97
|
USD 635,086
|
|
|
2024-01-16 |
2024-01-12 |
PS
Planned sale
|
ZERBE ROBERT L MD
Non-Executive Director
|
2,200
-6.6%
38.09
USD 83,798
|
2,200
-6.6%
|
38.09
|
USD 83,798
|
|
|
2023-12-15 |
2023-12-14 |
S
Sale
|
Wotton Paul K
Non-Executive Director
|
5,000
-15.7%
37.31
USD 186,550
|
5,000
-15.7%
|
37.31
|
USD 186,550
|
|
|
2023-12-15 |
2023-12-14 |
PS
Planned sale
|
Flynn Sean C.
SVP, General Counsel
Officer
|
106
-2.3%
37.45
USD 3,970
|
106
-2.3%
|
37.45
|
USD 3,970
|
|
|
2023-12-15 |
2023-12-14 |
PS
Planned sale
|
Colangelo Dominick
President and CEO
Executive Director
|
12,000
-6.6%
37.12
USD 445,440
|
12,000
-6.6%
|
37.12
|
USD 445,440
|
|
|
2023-12-15 |
2023-12-13 |
PS
Planned sale
|
Flynn Sean C.
SVP, General Counsel
Officer
|
1,432
-23.8%
34.20
USD 48,974
|
1,432
-23.8%
|
34.20
|
USD 48,974
|
|
